Listed

ImmunityBio, Inc.: Form 10-K for the period ended Dec 31, 2015

Filed with the SEC on Mar 30, 2016 and accepted by EDGAR at Mar 30, 2016, 13:00 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-10-01 to 2015-12-31$15.0kus-gaap:Revenues
Revenue12 months2015-01-01 to 2015-12-31$236.0kus-gaap:Revenues
Research and development12 months2015-01-01 to 2015-12-31$11.4mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2015-10-01 to 2015-12-31$25.8mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative12 months2015-01-01 to 2015-12-31$227.7mus-gaap:SellingGeneralAndAdministrativeExpense
Income tax12 months2015-01-01 to 2015-12-31−$301.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-10-01 to 2015-12-31−$26.8mus-gaap:NetIncomeLoss
Net income12 months2015-01-01 to 2015-12-31−$236.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-10-01 to 2015-12-31−$0.33us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2015-01-01 to 2015-12-31−$3.31us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2015-01-01 to 2015-12-31−$25.3mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure12 months2015-01-01 to 2015-12-31$2.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases12 months2015-01-01 to 2015-12-31$4.8mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2015-12-31$175.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current liabilitiesAt period end2015-12-31$6.1mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2015-12-31$356.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-16-015596. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.